New Research Peptide “Pepe-132” Inspired by Ancient New Zealand Frog Demonstrates Promising Anti-Aging Potential in Preclinical Studies
Boston, MA – April 25, 2026 – Apex BioTherapeutics today announced the successful development and early validation of Pepe-132, a fully synthetic 14-amino acid research peptide modeled after a rare…